Rethinking Lifestyle Diseases: From Risk Factors to Root Causes

Apr 1, 2026 | Health Tech

Image Source: AI-generated image for editorial use
Written by: Contributor
On behalf of: Life Science Daily News

Are we mistaking associations for true biological origins?

Despite significant advances in modern medicine, lifestyle diseases such as cardiovascular disease and diabetes continue to rise globally. These conditions are commonly described as “multifactorial,” attributed to a combination of diet, genetics, stress, sleep, and other variables. While this framework has been useful in identifying risk patterns, it may represent an incomplete understanding of disease causation.

A critical distinction that often goes unexamined is the difference between statistical association and biological causation.

In current medical thinking, risk factors are frequently treated as primary drivers of disease. However, an associated factor may not necessarily represent the initiating cause. As I often describe it, an associated factor is like a witness to an event—not the origin of it.

For instance, elevated LDL cholesterol is strongly associated with cardiovascular disease. Clinically, managing such markers plays an important role in reducing immediate risk and guiding treatment decisions. However, the presence of an association does not, by itself, explain the underlying biological processes that give rise to the condition.

This distinction has been recognized within the scientific community. Glass and McAtee have described the growing limitations of traditional risk factor epidemiology, pointing to what they term “causal ambiguity,” where associations are identified, but deeper mechanistic understanding remains unclear. Similarly, Vandenbroucke and colleagues have cautioned against conflating statistical correlations with true causation.

This brings us to what can be described as the “Firefighter Fallacy.” Observing firefighters at the scene of a fire does not imply they caused it. In the same way, identifying biomarkers associated with disease does not necessarily reveal the origin of the pathology. If interventions focus solely on modifying these markers without addressing underlying processes, we may be managing outcomes rather than resolving causes.

A more comprehensive approach may lie in shifting attention toward cellular-level processes and systems biology. Disease does not originate at the level of population statistics; it begins with changes in cellular function, tissue integrity, and biochemical balance. Understanding these foundational processes—what might be termed cellular pathogenesis—could provide deeper insight into why certain patterns, such as altered lipid profiles or impaired glucose metabolism, emerge.

This perspective does not dismiss the importance of lifestyle factors such as diet, physical activity, and sleep. On the contrary, these remain essential components of health. However, their role may be better understood not just as isolated risk modifiers, but as influences on underlying biological systems.

The key shift, therefore, is conceptual. It is a move from managing measurable indicators to exploring the origins of dysfunction. When causation is understood at a fundamental level, interventions can become more targeted, coherent, and potentially transformative.

In an era of increasing chronic disease burden, refining our understanding of causation may be just as important as advancing treatment. The challenge is not only to identify what is associated with disease, but to ask a deeper question:

Are we addressing the true origin of the problem—or its visible signals?


Author Bio

Dr. Balaram Dhotre

 

Dr. Balaram Dhotre is an author and disease reversal nutritionist focused on understanding the root causes of lifestyle diseases through nutrition and cellular health perspectives. His work explores the distinction between statistical associations and biological causation in chronic disease.

 

    References:  
    1. Glass TA, McAtee MJ. Behavioral science at the crossroads in public health: Extending horizons, envisioning the future. Social Science & Medicine. 2006;62(7):1650–1671.
    2. Vandenbroucke JP, Broadbent A, Pearce N. Causality and causal inference in epidemiology: The need for a pluralistic approach. International Journal of Epidemiology. 2016;45(6):1776–1786.
    3. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Lippincott Williams & Wilkins; 2008.
    4. Hill AB. The environment and disease: Association or causation? Proceedings of the Royal Society of Medicine. 1965;58(5):295–300.

    Articles that may be of interest

    Evaluating Retrieval Systems for Clinical AI

    Evaluating Retrieval Systems for Clinical AI

    Clinical decision support is not new, and it does not have to be complex to work. If anything, the simpler it is, the more likely clinicians are to use it. The best-known earlier example is the WHO surgical safety checklist, developed by a team led by Atul Gawande,...

    read more
    The Security Blind Spot in Life Science Digitalization

    The Security Blind Spot in Life Science Digitalization

    The life sciences sector is in the midst of a digital transformation that most security teams were not built to handle. AI-driven drug discovery platforms, cloud-connected lab equipment, genomic databases, and real-time patient data pipelines are creating attack...

    read more
    Making AI Work in a Regulated Medtech Industry

    Making AI Work in a Regulated Medtech Industry

    For several years, AI has been viewed as one of the biggest opportunities for the medtech sector. With an industry survey finding that 91% of leaders were enthusiastic about its potential, early conversations centred on how it could transform healthcare delivery and...

    read more

    Articles that may be of interest

    Evaluating Retrieval Systems for Clinical AI

    Evaluating Retrieval Systems for Clinical AI

    Clinical decision support is not new, and it does not have to be complex to work. If anything, the simpler it is, the more likely clinicians are to use it. The best-known earlier example is the WHO surgical safety checklist, developed by a team led by Atul Gawande,...

    read more
    The Security Blind Spot in Life Science Digitalization

    The Security Blind Spot in Life Science Digitalization

    The life sciences sector is in the midst of a digital transformation that most security teams were not built to handle. AI-driven drug discovery platforms, cloud-connected lab equipment, genomic databases, and real-time patient data pipelines are creating attack...

    read more
    Making AI Work in a Regulated Medtech Industry

    Making AI Work in a Regulated Medtech Industry

    For several years, AI has been viewed as one of the biggest opportunities for the medtech sector. With an industry survey finding that 91% of leaders were enthusiastic about its potential, early conversations centred on how it could transform healthcare delivery and...

    read more